Trial Profile
Clinical and Metabolic Effects of Rosiglitazone on Women with Polycystic Ovarian Syndrome.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 May 2012
Price :
$35
*
At a glance
- Drugs Rosiglitazone (Primary)
- Indications Polycystic ovary syndrome
- Focus Pharmacodynamics
- 30 Jun 2011 Results published in Fertility and Sterility.
- 08 Jan 2010 New trial record